Dr. David Soria speaks about a new study published in the British Medical Journal Open that says prescription strength, proton-pump inhibitors are associated with a potential 25 percent increased risk of early death from any cause.
At prescription strength, proton-pump inhibitors are associated with a potential 25% increased risk of early death from any cause, suggests new research published Monday in the British Medical Journal Open.
Posted at
and last updated
Copyright 2016 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
